Multiple Sclerosis Society of Canada



  • Brand name: Gilenya (Novartis Pharmaceuticals Canada Inc.)
  • Route of Administration: Oral capsule
  • Approved for treatment in RRMS. Clinical phase III trial investigating the efficacy of its treatment in delaying disability progression in progressive MS is underway.

Click here for information on Gilenya as a treatment for RRMS.